No Prescription

Alpha Index E

No Prescription » Products » Alpha Index E

List of Drugs:

A  B  C  D  E  F  G  H  I  K  L  M  N  O  P  Q  R  S  T  U  V  W  X  Z  #

Products E:

EaseSure

Easibreathe Karvol

EasyTravel Solution

EBUTOL Myambutol

ECOSPRIN ASA

Edronax Generic Reboxetine

EFAVIR Sustiva

EFEXOR Effexor XR

Efexor XR Effexor XR

Effexor (Venlafaxine)

Effexor XR Generic Venlafaxine

Eflora Cream Vaniqa

Efudix Generic Fluorouracil

Elavil (Amitriptylin)

Eldepryl (Selegiline)

Elidel Cream Generic Pimecrolimus Cream

Elimite (Permethrin)

ELMA Generic Lignocaine

ELOCON Cutizone

Elogen Mircette

ELTROXIN Levothroid

Emeset MD Zofran ODT

EMESET Zofran

Emetil Largactil

Emla cream Generic Lidocaine

Emulgel (Dicloflam)

E Mycin Ery C

E MYCIN Grans Oral Susp Ery C

Enapril Vasotec

ENCORATE CRONO Depakote

ENCORATE Depakene

ENCRIPT Parlodel

Energy Tonic

Enhance9

Enselin MF Forte Avanadmet

Entocort Generic Budesonide

Epanutin Generic Phenytoin sodium

Epina Eye Drops Relestat

Epivir (Lamivudine)

Eptus Inspra

ERYCIN Althrocin

Erythrocin Tiloryth

Esidrix (Hydrochlorothiazide)

Estelle 35ED Diane 35

Estrace (Estradiol)

Estraderm TTS 100 Generic Estradiol

Estraderm TTS 25 Generic Estradiol

Estradot

Estrin Cenestin

Estriol Vaginal Cream Generic Ovestin

Estrofem Generic Estradiol

Ethambutol Generic Myambutol

Ethinyl Estradiol Generic Estrace

Ethinyloestradiol Generic Estrace

ETOSID VP 16

Eulexin (Flutamide)

Eumosone M Cream Temovate

EURYTHMIC Cordarone

Evalon Ovestin

Evalon Vaginal Cream Ovestin

Everlast Priligy

Evista Generic Raloxifene

Evista (Raloxifene)

Exelon Oral Solution Generic Rivastigmine

Exelon Generic Rivastigmine

Exelon (Rivastigmine)

Exermet P 515 Actosplus Met

Eye-Heal

EZEDOC Zetia

EZETROL Zetia

Previous  Next

No Prescription: NEW YORK, Oct. 5, 2011 /PRNewswire via COMTEX/ -- Reportlinker.com announces that a new market research report is available in its catalogue: European Pharmaceutical Market: Strategic Assessments of Leading Suppliers http://www.reportlinker.com/p0651431/European-Pharmaceutical-Market-Strategic-Assessments-of-Leading-Suppliers.html #utm_source=prnewswire&utm_medium=pr&utm_campaign=Drug_and_Medication This report provides industry executives with strategically significant competitor information and analysis of the leading players in the European pharmaceutical market. The report provides a worldwide strategic overview of the pharmaceutical market, including: Sales forecast for major product segments: ethical, OTC, generics. Sales forecast for major drug categories: cardiovascular, gastrointestinal, antibiotic, CNS, respiratory, musculoskeletal, hormonal/genitourinary, dermatological, oncological, ophthalmic, and others. In addition, the report reviews major regulatory, technological, economic, demographic, and social trends with potentially significant impact on the market during the next five years, including discussion of such key issues as pricing, industry consolidation, market globalization, growing R&D cost, generics, as well as advances in genomics, proteomics, drug screening, tissue engineering, bioinformatics, and other technologies. The companies analyzed in this report include Abbott, AstraZeneca, Bristol-Myers Squibb, Eli Lilly, GlaxoSmithKline, Johnson & Johnson, Merck, Novartis, Pfizer, Roche, Sanofi-Aventis and Wyeth.